The study further explores and provides an in-depth analysis of current market dynamics and recent trends, focusing on various key factors and potential growth opportunities and risks. The report focuses on leading regions and their major countries to anticipate market growth in the forecast years.

The global predictive biomarkers market is expected to register a revenue CAGR during the forecast period. Increase in number of clinical trials is a key factor driving market revenue growth during the forecast period. In addition, developments and advancements in this field are expanding. Approximately, 427,086 clinical studies are currently under trial globally. Predictive biomarkers are also utilized to identify patients who will benefit from adjuvant radio- and or chemotherapy. Predictive biomarkers can help with patient care decisions like choosing between different interventions or figuring out which patients would benefit from a particular treatment. For instance, Kirsten Ras (KRAS) is a frequently mutated oncogene in colorectal cancer and a predictive biomarker for Epidermal Growth Factor (anti-EGFR) monoclonal antibody therapy resistance. According to MD Anderson Cancer, KRAS mutations are among the most prevalent gene mutations associated with cancer, found in about 25% of malignancies.

Increasing cases of cardiovascular disorders and others is a major factor contributing to revenue growth of the market. Major companies are focusing on product launches for new companion diagnostics for different cancers. For instance, on 10 October 2020, F. Hoffmann-La Roche Ltd stated that the Cobas EGFR Mutation Test v2 has received approval from the U.S. Food and Drug Administration (FDA) for expanded claims as a Companion Diagnostic (CDx) for a wider range of medicines in the treatment of Non-Small Cell Lung Cancer (NSCLC). According to the approved therapeutic product labeling, this claim expansion enables the test to be used as a CDx for all five Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) medicines currently approved by the FDA that target EGFR mutations L858R and Exon 19 deletions.

Get Free Exclusive Sample PDF Copy @ https://www.emergenresearch.com/request-sample/261

Key Highlights of the Report:

• The report offers a comprehensive overview of the Predictive Biomarkers Market along with historical analysis and an accurate forecast estimation
• The report covers extensive analysis of the Predictive Biomarkers Market segmentation based on product types, applications, end-user industries, and key regions
• Extensive coverage of the competitive landscape along with product portfolio, production and manufacturing capacity, and strategic alliances and business expansion plans
• In-depth analysis of the market drivers, restraints, limitations, risks, threats, and growth prospects in the market
• Strategic recommendations to the established players and new entrants to help them gain a robust footing in the industry

Predictive Biomarkers Market: Dynamics

The Global Predictive Biomarkers Market is predominantly driven by the increase in cancer incidences across the globe, augmenting the applications of biomarkers in cancer diagnosis. Moreover, augmented investments and funding for the advancements for Research and Development in pharmaceutical companies and biotechnology companies by government and non-government bodies are further driving the market's growth.

Major Players/Manufacturers profiled in the report are:

• Roche Diagnostic Limited
• Siemens Healthcare
• Abbott Laboratories
• Qiagen
• Johnson and Johnson
• E. Healthcare
• PerkinElmer, Inc.
• Merck KGaA
• Thermo Fisher Scientific, Inc.
• Affymetrix, Inc.

Request a discount on the report @ https://www.emergenresearch.com/request-discount/261

Emergen Research has segmented the global Predictive Biomarkers based on product, Application and region:

Product Type:

• Cancer
• Neurological Disorders
• Immunological Disorders
• Cardiovascular Disorders

Application:

• CROs
• Biopharmaceutical Companies
• Academic and Research Institutes
• Diagnostic Centers

Key Benefits of the Report:

1. Comprehensive analysis of the competitive scenario and its changing dynamics
2. Analytical data with detailed SWOT analysis and Porter’s Five Forces analysis
3. In-depth 8 Year analysis of the Global predictive biomarkers Market
4. Critical assessment of the key market segments
5. Comprehensive analysis of the drivers, restraints, trends, and opportunities
6. Detailed regional analysis and extensive company profiling
7. Extensive assessment of current and emerging trends of the market

Click here to Buy Now @ https://www.emergenresearch.com/select-license/261

Thank you for reading our report. The report can be customized according to the requirements of the clients. Please get in touch with and our team will ensure the customization is as per your needs.

Read similar reports by Emergen Research:

Agricultural Robotics Market

https://www.emergenresearch.com/industry-report/agricultural-robotics-market

hydrogen aircraft market

https://www.emergenresearch.com/industry-report/hydrogen-aircraft-market

Hydraulics Market

https://www.emergenresearch.com/industry-report/hydraulics-market

Protein Chip Market

https://www.emergenresearch.com/industry-report/protein-chip-market

Botulinum Toxin Market

https://www.emergenresearch.com/industry-report/botulinum-toxin-market

Wireless Display Market

https://www.emergenresearch.com/industry-report/wireless-display-market

Stool Softener Market

https://www.emergenresearch.com/industry-report/stool-softener-market

Diphenylmethane Diisocyanate Market

https://www.emergenresearch.com/industry-report/diphenylmethane-diisocyanate-market

CAR-T cell therapy Market

https://www.emergenresearch.com/industry-report/car-t-cell-therapy-market

Laser Technology Market

https://www.emergenresearch.com/industry-report/laser-technology-market

Biosurfactants Market

https://www.emergenresearch.com/industry-report/biosurfactants-market

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: [email protected]

Visit for More Insights: https://www.emergenresearch.com/insights

Explore Our Custom Intelligence services | Growth Consulting Services

Latest Reports: video surveillance market | hair styling market

Trending Titles: license management market | smart transportation market